Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Go back to Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Guardant Health (GH) PT Raised to $60 at BTIG

February 21, 2025 6:19 AM EST

BTIG analyst Mark Massaro raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "Guardant had an excellent 2024 and investor sentiment has significantly shifted positive (rightly so, in our view) as the... More